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ARTICLE
Bivariate causal mixture model quantifies polygenic
overlap between complex traits beyond genetic
correlation
Oleksandr Frei 1, Dominic Holland2,3,12, Olav B. Smeland 1,4,12, Alexey A. Shadrin1, Chun Chieh Fan 2,5,6,
Steffen Maeland1, Kevin S. O’Connell 1, Yunpeng Wang1,2,6, Srdjan Djurovic 7,8, Wesley K. Thompson9,10,
Ole A. Andreassen 1,4 & Anders M. Dale2,3,6,11
Accumulating evidence from genome wide association studies (GWAS) suggests an abun-
dance of shared genetic influences among complex human traits and disorders, such as
mental disorders. Here we introduce a statistical tool, MiXeR, which quantifies polygenic
overlap irrespective of genetic correlation, using GWAS summary statistics. MiXeR results
are presented as a Venn diagram of unique and shared polygenic components across traits.
At 90% of SNP-heritability explained for each phenotype, MiXeR estimates that 8.3 K var-
iants causally influence schizophrenia and 6.4 K influence bipolar disorder. Among these
variants, 6.2 K are shared between the disorders, which have a high genetic correlation.
Further, MiXeR uncovers polygenic overlap between schizophrenia and educational attain-
ment. Despite a genetic correlation close to zero, the phenotypes share 8.3 K causal variants,
while 2.5 K additional variants influence only educational attainment. By considering the
polygenicity, discoverability and heritability of complex phenotypes, MiXeR analysis may
improve our understanding of cross-trait genetic architectures.
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In recent years, genome-wide association studies (GWASs)have successfully detected genetic variants associated withmultiple complex human traits or disorders, providing
important insights into human biology1. Understanding
the degree to which complex human phenotypes share
genetic influences is critical for identifying the etiology of
phenotypic relationships, which can inform disease nosology,
diagnostic practice, and improve drug development. Most human
phenotypes are known to be influenced by multiple genetic var-
iants, many of which are expected to influence more than one
phenotypes (i.e., exhibit allelic pleiotropy)2,3. This has led to
cross-trait analyzes, quantifying polygenic overlap, becoming a
widespread endeavor in genetic research, made possible by the
public availability of most GWAS summary statistics (p-values
and z-scores)4,5.
Currently, the prevailing measure to quantify polygenic
overlap is genetic correlation. For a pair of traits, polygenic
overlap refers to the fraction of genetic variants causally asso-
ciated with both traits over the total number of causal variants
across the two traits considered, while genetic correlation quan-
tifies the correlation coefficient of additive genetic effects for
the two traits. The sign of the correlation indicates whether the
shared genetic effects predominantly have the same or the
opposite effect directions. Available methods can quantify
genetic correlation using raw genotypes6,7 or GWAS summary
statistics8–11. However, these methods report overall positive,
negative, or no genetic correlation, but fail to capture mixtures of
effect directions across shared genetic variants. This scenario is
exemplified by the genetic relationship between schizophrenia
and educational attainment. Despite consistent estimates of a
non-significant genetic correlation12,13, many genome-wide sig-
nificant loci are found to be jointly associated with both phe-
notypes14. Among 25 shared loci15, 16 had effects in the opposite
direction, while 9 had effects in the same direction. Thus, new
statistical tools are needed to improve our understanding of the
polygenic architecture of complex traits and their intricate
relationships.
Here, we introduce a statistical tool (MiXeR), which quanti-
fies polygenic overlap irrespective of genetic correlation between
traits, using summary statistics from GWAS. To evaluate
polygenic overlap between two traits, MiXeR estimates the total
number of shared and trait-specific causal variants (i.e., variants
with nonzero additive genetic effect on a trait). MiXeR bypasses
the intrinsically difficult problem of detecting the exact location
of causal variants, but rather aims at estimating their overall
amount. MiXeR builds upon the univariate causal mixture
model16–19, which we extend to four bivariate normal dis-
tributions as illustrated in Fig. 1, with two causal components
for variants specific to each trait, one causal component for
variants affecting both traits, and a null component for variants
with no effect on either trait. From the prior distribution of
genetic effects, we derive the likelihood function of the observed
signed test statistics (GWAS z-scores), incorporating effects of
linkage disequilibrium (LD) structure, minor allele frequency
(MAF), sample size, cryptic relationships, and sample overlap.
The parameters of the mixture model are estimated from the
summary statistics by direct optimization of the likelihood
function.
We show in simulations that MiXeR provides accurate esti-
mates of model parameters in the presence of realistic LD
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Fig. 1 Components of the bivariate mixture in three scenarios of polygenic overlap. All figures are generated from synthetic data, where causal variants
were drawn from the MiXeR model, the total polygenicity in each trait is set to 0.01%, SNP heritability is set to 0.4, GWAS N= 100,000. First column
shows two traits where causal variants do not overlap. Second column adds a component of causal variants affecting both traits in the same (concordant)
direction. Third column shows a scenario of polygenic overlap without genetic correlation. Top row shows simulated bivariate density of additive effects of
allele substitution (β1j, β2j), the bottom row shows bivariate density of GWAS signed test statistics (z1j, z2j) for GWAS SNPs (genotyped or imputed). Due
to linkage disequilibrium, GWAS-signed test statistic has substantially larger volume of SNPs associated with the phenotype. The aim of the MiXeR model
is to infer distribution of causal effects (top row), using GWAS data (bottom row) as an input. Figures are generated on a regular grid of 100 × 100 bins,
color histogram indicates log10(N) where N is the number of SNPs projected into a bin
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structure. Using GWAS summary data, we quantify polygenic
overlap of several psychiatric disorders, including schizophrenia
and bipolar disorder, with educational attainment and human
height, with large implications for understanding how genetic
factors overlap between complex human phenotypes.
Results
Simulations studies. In our first set of simulations, we generated
synthetic GWAS data that follow model assumptions and asses-
sed the validity of MiXeR estimates (polygenic overlap, π12;
correlation of effect sizes within the shared polygenic component,
ρ12, and genetic correlation, rg) in the presence of a realistic LD
structure (Fig. 2). We observed no bias in the estimates across a
wide range of simulation scenarios (Supplementary Figs. 1–3),
except for the scenario with low heritability (h2= 0.1) and high
polygenicity (πu1 ¼ 3´ 103) in both traits, which represents an
insufficiently powered GWAS study. In this scenario, MiXeR
shows large variation among the estimates, and reports a non-
zero polygenic overlap, when no such overlap exists. Standard
errors estimated by the model are shown in Supplementary
Table 1. Similarly, we show that univariate estimates of poly-
genicity and heritability are correct in all scenarios (Supplemen-
tary Fig. 4, Supplementary Table 2), except for the same scenario
with low heritability and high polygenicity. In this scenario, a
large variation among the polygenicity estimates suggests that the
biases can be explained by truncated distribution of the errors, as
the polygenicity parameters π1, π2, and π12 are bound to be non-
negative. Traits with low heritability should obtain correct MiXeR
estimates when the GWAS are sufficiently powered.
In addition, we validated that the model accurately predicts
GWAS quantile–quantile (Q–Q) plots (Supplementary Fig. 5)
and detailed Q–Q plots with SNPs partitioned into disjoint
groups according to MAF and LD score (Supplementary Fig. 6a,
b). Detailed Q–Q plots show a stronger GWAS signal for SNPs
with higher MAF and higher LD score. The model’s prediction
follows the same pattern, indicating that it correctly captures
dependency of GWAS association statistics on MAF and LD
score. To validate the accuracy of the predicted bivariate density,
we generated conditional Q–Q plots (Supplementary Fig. 7),
showing observed versus expected −log10 p-values in the primary
trait as a function of significance of association with a secondary
trait at the level of p ≤ 0.1, p ≤ 0.01, and p ≤ 0.001. We note that
data Q–Q plots are closely reproduced by the model predictions
across all p-value strata. Interestingly, scenarios without polygenic
overlap show an enrichment, arising because GWAS p-values
depend on allele frequency and LD structure, though this effect is
generally smaller than enrichment arising due to shared causal
variants.
Sensitivity analysis. For sensitivity analysis, we conducted simu-
lations with traits that have a shared pattern of differential
enrichment of heritability across genomic categories20, which are
not accounted for by the MiXeR model. Simulations were
informed by the enrichment pattern of schizophrenia21, as esti-
mated by stratified LD score regression22 (Supplementary Fig. 8a).
In the univariate analysis, polygenicity was underestimated by
about 20% (Supplementary Fig. 9), suggesting that the model
likely groups adjacent causal variants together and interpret their
combined effect as arising from a single variant. In the bivariate
analysis, we observed a small upwards bias in the estimate of
polygenic overlap (Supplementary Table 3), but it did not exceed
10% of the polygenicity across all sufficiently powered scenarios.
Another assumption in the MiXeR model is that effect sizes are
independent of allele frequencies. To asses this assumption, we
ran simulations with effect sizes drawn from the BayesS19 model
(see Online Methods). It characterizes MAF-dependent architec-
ture in terms of a single parameter S, ranging from S= 0
(equivalent to the MiXeR assumptions) to S=−1 (equivalent to
the LDSR assumption). We simulated three intermediate values,
S=−0.25, S=−0.5, and S=−0.75, which cover the range of
BayesS estimates observed for real GWAS data. The results
(Supplementary Fig. 10, Supplementary Tables 2, 4) highlight
certain biases in MiXeR parameter estimates: for the extreme case
of S=−0.75, heritability (h2), univariate polygenicity (πu1), and
polygenicity of the shared genetic component (π12) are under-
estimated by up to 25%; correlation of effect sizes (ρ12) is
overestimated by 25%; however, the genome-wide genetic
correlation (rg) appears to have no bias.
Finally, we ran simulations with an incomplete reference, and
simulated phenotypes where causal variants were spread across
our entire reference panel of N= 11,015,833 variants, but only a
fraction (50, 25, or 12.5%) of the variants enter LD structure
estimation and fit procedure. The results (Supplementary
Table 5) show that the total number of causal SNPs, as well
as the heritability, are estimated correctly, while the poly-
genicity parameter is different from the simulated value,
because it reflects the fraction of all tagged causal variants
with respect to the reference that went into LD structure
estimation.
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Fig. 2 Selected simulations with bivariate model: a the estimates of polygenic overlap; b the estimates of correlation of the effect sizes in shared polygenic
component; c the estimates of genetic correlation. The bars in blue indicate an average value of model estimates across ten simulation runs. The bars in
cyan show true (simulated) parameters. Error bars represent standard deviation of the model estimate across ten simulation runs. Individual simulation
runs are shown as dot points. Different bars correspond to levels of polygenic overlap: from zero (no overlap) to complete polygenic overlap. Simulated
heritability is 0.4, simulated fraction of causal variants is 0.03% in both traits
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GWAS summary statistics. We applied MiXeR to summary
statistics from GWAS of 14 phenotypes, including five
psychiatric21,23–26 and four autoimmune27,28 diseases, four
anthropomorphic traits29–32, and educational attainment12 (see
Supplementary Table 6 for metadata about the studies).
MiXeR estimates of genetic correlation (Table 1; Supplemen-
tary Table 7) were generally consistent with those of cross-trait
LD Score Regression8, with the highest genetic correlation
observed between schizophrenia and bipolar disorder. As
expected, these disorders also exhibit substantial polygenic
overlap, sharing 6.2 K out of 8.5 K causal variants involved. Here
and below, the numbers of causal variants are reported as 22.6%
of their total estimate, which jointly accounts for 90% of SNP
heritability in each phenotype, to avoid extrapolating model
parameters into the area of infinitesimally small effects (Supple-
mentary Fig. 11).
Furthermore, MiXeR reveals important differences among
traits with low genetic correlation, represented as Venn diagrams
of shared and unique polygenic components (Fig. 3; Supplemen-
tary Figs. 12, 13a–g). For example, schizophrenia and educational
attainment exhibit substantial polygenic overlap, sharing 8.3 K
out of 10.8 K of causal variants involved. On the contrary,
schizophrenia and height share only about 0.8 K out of 10.6 K
causal variants. Educational attainment and height also show low
polygenic overlap, sharing 1.8 K out of 12.3 K causal variants.
Nevertheless, these traits have a high correlation of effect sizes
within the shared component, ρ12= 0.52 (0.04), which at
genome-wide level is observed as genetic correlation of rg=
0.16 (0.01) according to MiXeR, or rg= 0.14 (0.01) according to
LDSR.
MiXeR estimates of the unique polygenic components provide
insights into trait-specific genetic architectures. For example,
schizophrenia has 2.1 K causal variants not shared with bipolar
disorder, less than 0.1 K variants not shared with educational
attainment, but as many as 7.5 K variants not shared with height.
Also, for the other phenotypes, the number of trait-specific causal
variants varies across different pairs of traits (Fig. 3).
Figure 4 and Supplementary Fig. 14a–g visualize the observed
bivariate density of the GWAS-signed test statistics (z1j, z2j), the
predicted density z^1j; z^2j
 
from the MiXeR model, and the
estimated bivariate density of the additive causal effects (β1j, β2j)
that underlie model predictions. Figure 4 gives real examples for
the three different scenarios of polygenic overlap (genetically
independent traits, polygenic overlap with and without genetic
correlation, as shown in Fig. 1). Finally, we use conditional Q–Q
plots33,34 to compare the observed and predicted distributions of
z-scores, and show that MiXeR-based prediction provides
accurate estimates of the data Q–Q plots (Fig. 5), both in
univariate and bivariate contexts.
Discussion
MiXeR is a statistical method for cross-trait analysis of GWAS
summary statistics, which enables a more complete quantification
of polygenic overlap than provided by the LD score regression
method8. In addition to genetic correlation, MiXeR estimates the
total number of shared and trait-specific causal variants, pro-
viding new information about the genetic relationships between
complex traits and disorders.
MiXeR extends cross-trait LD score regression8 by incorpor-
ating a causal mixture model16–19, thus relying on a biologically
more plausible prior distribution of genetic effect sizes compared
with the infinitesimal model35,36. We show that polygenicity,
measured as a total number of causal variants, and discover-
ability37, measured as variance of additive genetic effects across
causal variants, have major implications for the future of GWAS
discoveries (Supplementary Fig. 15).
Applying MiXeR to real phenotype data, we provide new
insights into the genetic relationships between schizophrenia,
bipolar disorder, educational attainment, and height. In line with
the strong clinical relationship38 between schizophrenia and
bipolar disorder, and prior genetic studies25,34,39,40, we find
substantial polygenic overlap between the two disorders. Other
studies have reported more substantial genetic differences
between the disorders40 (albeit with strong correlation40,41), likely
because they did not specifically model the polygenic overlap. For
Table 1 The results of cross-trait analysis with the MiXeR model for schizophrenia (SCZ), bipolar disorder (BIP), educational
attainment (EDU) and height
Trait 1 Trait 2 n12 (se) n1 (se) n2 (se) ρ12 (se) rg (se) rgLDSR (se)
SCZ BIP 6.19 (0.99) 2.10 (1.26) 0.21 (0.44) 0.853 (0.019) 0.725 (0.071) 0.725 (0.024)
SCZ EDU 8.29 (0.84) 0.00 (0.04) 2.54 (1.02) 0.071 (0.015) 0.062 (0.014) 0.079 (0.022)
SCZ Height 0.83 (0.10) 7.46 (0.87) 2.29 (0.12) −0.045 (0.060) −0.007 (0.010) −0.008 (0.019)
BIP EDU 5.72 (1.46) 0.68 (1.16) 5.11 (1.58) 0.278 (0.051) 0.191 (0.036) 0.188 (0.023)
BIP Height 0.83 (0.11) 5.57 (1.11) 2.29 (0.13) 0.001 (0.067) 0.000 (0.013) −0.014 (0.021)
EDU Height 1.76 (0.11) 9.07 (0.58) 1.37 (0.10) 0.519 (0.040) 0.157 (0.010) 0.141 (0.012)
Columns: n12 – estimated number of shared causal variants, reported in thousands; n1 (n2)– estimated number of causal variants, unique to trait 1 (trait 2), reported in thousands; ρ12 – correlation of effect
sizes in shared polygenic component; rg – genetic correlation (rg ¼ ρ12π12=
ffiffiffiffiffiffiffiffiffiffi
πu1 π
u
2
p
, see Online Methods); rgLDSR—estimate of genetic correlation from LD Score Regression. The number of variants (n12,
n1, and n2) are adjusted to explain 90% of heritability in the corresponding component. Parameters are fitted using approximately 1.1 M HapMap3 SNPs
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example, Ruderfer et al.40 performed a combined GWAS of
schizophrenia and bipolar disorder, and a differential GWAS of
schizophrenia cases versus bipolar disorder cases. Our results
indicate a higher polygenicity of schizophrenia than bipolar dis-
order, which is in line with the recent study by Bansal et al.14,
who highlighted two schizophrenia subtypes. Our results also
indicate that both schizophrenia and bipolar disorder have a
small fraction of causal variants conferring disorder-specific risk
(Fig. 3). Identifying shared and disorder-specific genetic variants
is a subject of our future research, as it could provide critical
knowledge about the distinct genetic architectures underlying
these psychiatric disorders. Moreover, we find that nearly all
causal variants influencing schizophrenia risk also appear to
influence educational attainment, despite a genetic correlation
close to zero (Table 1). This is in line with recent studies
demonstrating shared genetic loci between schizophrenia and
educational attainment15 and a strong genetic dependence
between the phenotypes possibly related to different subtypes of
schizophrenia14. In contrast, while 89% of genetic variants
influencing bipolar disorder also appear to influence educational
attainment, there is in this case a significant positive genome-
wide correlation of 0.191 (0.036), in agreement with the cross-
trait LD score regression estimate of 0.188 (0.023) (Table 1;
Supplementary Table 7).
We show that polygenicity is best expressed as a total number
of causal variants (Supplementary Table 5). Previous studies
presented it as a fraction, which is highly dependent on the
reference panel used (1.1 M hapmap in ref. 18, or 484 K Affy-
metrix SNPs in ref. 19). When expressed as a total number, our
estimates of polygenicity are consistent with previously reported
results19 (Supplementary Table 8). In addition, we estimate that
under the assumptions of the MiXeR model, only 5% of causal
variants are needed to explain 50% of heritability, and 22.6% of
causal variants are needed to explain 90% of heritability (Sup-
plementary Fig. 11). These numbers are expected to be less
dependent on modeling assumptions, because with finite GWAS
samples it is not possible to distinguish small effects from truly
null effects. The actual number of causal variants is, potentially,
even higher, as our model tends to clump together variants if they
are in high LD with each other (Supplementary Tables 3, 4).
Some existing methods can already uncover polygenic overlap
in the absence of genetic correlation. For example, conjFDR
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analysis33,34 is a non-parametric model-free approach, which
detects shared genetic loci regardless of their allelic effect direc-
tions, by prioritizing variants with strong associations across
more than one GWAS42. Other methods, including gwas-pw43
and HESS44, also aim at detecting genomic loci jointly associated
with two traits. MiXeR complements these methods by providing
an easily interpretable high-level overview of the shared and
unique genetic architectures underlying complex phenotypes.
Among other notable methods for cross-trait analysis, the Gen-
omicSEM9 and MTAG11 represent a multi-trait extension of the
LD score regression. They can handle two or more traits at a time,
but are based on the infinitesimal assumption, and quantify
polygenic overlap using genetic correlation. For two-trait analysis,
these methods are equivalent to LD score regression, thus we did
not perform a formal comparison between GenomicSEM,
MTAG, and MiXeR.
MiXeR has some notable advantages compared with the
existing methods that implement causal mixture. First, our
mathematical model for the likelihood term p(zj|βj) is con-
ceptually simpler and more flexible, resulting in unbiased esti-
mates of model parameters across a wide range of simulation
scenarios (Supplementary Figs. 1–3) and providing accurate
prediction of GWAS z-scores across varying ranges of MAF and
LD (Supplementary Fig. 6a, b). Second, MiXeR implementation
works well with a large reference of 10M variants, while other
methods have reduced the reference to 1.1 M HapMap SNPs
(ref. 18) or 484 K Affymetrix SNPs (ref. 19). Finally, our model
individually processes all SNPs, without grouping them into bins
(ref. 16).
MiXeR models causal effects as a single Gaussian component,
while recent work18,45 suggests that certain phenotypes,
including height, require at least two causal components of
small and large effects. We note that the MiXeR model still
provides a good fit for SNPs not reaching the GWAS sig-
nificance threshold (Supplementary Fig. 16) and shows devia-
tions only toward the tail of the distribution. To further
investigate the effects of model misspecification, we imple-
mented right-censoring of genome-wide significant SNPs (see
Online methods). The results (Supplementary Tables 7, 9) are
consistent with our main analysis, except for height which
received a lower estimate of heritability (65% instead of 70%), a
slight increase in polygenicity, and increased polygenic overlap
with other traits. We propose that for a better estimate of
height’s polygenicity, it would be beneficial to run MiXeR on a
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Fig. 5 Conditional Q–Q plots of observed versus expected −log10 p-values in the primary trait as a function of significance of association with a secondary
trait at the level of p≤ 0.1 (orange lines), p≤ 0.01 (green lines), p≤ 0.001 (red lines). Blue line indicates all SNPs. Dotted lines in blue, orange, green, and
red indicate model predictions for each stratum. Black dotted line is the expected Q–Q plot under null (no SNPs associated with the phenotype). Points on
the Q–Q plot are weighted according to LD structure, using n= 64 iterations of random pruning at LD threshold r2= 0.1
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residualized GWAS, after covarying association statistics for
genotypes of all genome-wide significant SNPs.
Recent work suggests the importance of MAF- and LD-
dependent genetic architectures19,46, which are not directly
modeled by MiXeR. Our simulations show certain biases in the
estimates of polygenicity parameters (πu1 and π12), which under-
estimate the true value by up to 25% in the case of extreme MAF-
dependent architecture with S=−0.75 (Supplementary Fig. 10).
However, these biases tend to cancel one another out when
considering the relative size of the polygenic overlap (π12=π
u
1
ratio). Also, on real data, most BayesS19 estimates lay between
S=−0.25 and S=−0.5, where the bias of the MiXeR estimates is
in the order of 10% rather than 25%. On real data, we observe
effects of MAF-dependent architectures by drawing Q–Q plots for
subsets of SNPs (Supplementary Fig. 17a–g) partitioned into nine
groups according to MAF and LD score, where the model tends
to underestimate z-scores in low MAF bins. This effect, however,
is quite subtle, and does not manifest itself on the overall Q–Q
plots (Supplementary Fig. 16).
The MiXeR method requires large GWAS studies. Our
recommendation is to apply MiXeR to studies with at least N=
50,000 participants, and inspect standard errors reported by
MiXeR. In addition, MiXeR applies Bayesian information criter-
ion (BIC) to compare causal mixture model versus the infinite-
simal model, as shown in Supplementary Table 9. The cases
where BIC selects the infinitesimal model indicate that the GWAS
sample size is insufficient to reliably fit the polygenicity para-
meter. Generally, polygenicity estimation requires more GWAS
power than heritability estimation, which can be visually
explained by GWAS Q–Q plots (Supplementary Fig. 16): herit-
ability is determined by the overall departure of the GWAS curve
from the null line, while polygenicity is determined by its cur-
vature, i.e., the point where the GWAS curve begins to bend
upward from the null line, which is harder to estimate when
GWAS signal is weak. This is captured by MiXeR standard errors,
which show that individual parameters of the mixture model
have lower estimation accuracy than their combinations—for
example, relative errors for π1 and σ2β are larger than for the
heritability estimate h2 / π1σ2β, due to inversely-correlated errors
(Supplementary Table 2). Despite these limitations, there is still a
clear minimum on the energy landscape of cost function (Sup-
plementary Figs. 18, 19, showing log-likelihood as a function of
model parameters around the optimum).
In our future work, we plan to incorporate an additional
Gaussian component to model small and large effects18, and to
explicitly account for MAF-dependent architectures46. Further
extensions may account for differential enrichment for true
associations across genomic annotations20. Another limitation to
address is that the MiXeR model assumes similar LD structure
among studies, and is not currently applicable for analysis across
different ethnicities. We also aim to extend the MiXeR modeling
framework to be used to improve power for discovery of shared
and trait-specific SNPs by estimating the posterior effect size of
SNPs associated with one trait given the test statistics in another
trait, as well as for improving predictive power of polygenic risk
scores.
In conclusion, MiXeR represents a useful addition to the
toolbox for cross-trait GWAS analysis. By considering the intri-
cate polygenic architectures of complex phenotypes, MiXeR
allows for measures of polygenic overlap beyond genetic corre-
lation. We expect this to lead to new insights into the pleiotropic
nature of human genetic etiology.
Methods
Bivariate causal mixture model. Consider a simple additive model of genetic
effects, ignoring gene-environment interactions, epistasis and dominance effects.
Under these assumptions, the contribution of the genotype to the phenotype is
modeled as a sum of individual contributions from genetic variants: yk ¼
P
j gjkβj ,
where yk is a quantitative phenotype or disease liability of k-th individual, gjk is 0, 1,
2-coded number of reference alleles for j-th variant, and βj is the additive genetic
effect of allele substitution. We say that a genetic variant is causal for a trait if it has
a non-zero effect on that trait (βj ≠ 0).
MiXeR builds upon the univariate causal mixture model16,
βj  π0N 0; 0ð Þ þ π1N 0; σ2β
 
, which assumes that only a small fraction (π1) of
variants have an effect on the trait, while the effect of the remaining variants is zero.
For the mathematical convenience, we chose a Gaussian distribution for the non-
null arm of the causal mixture. A drawback with the gaussian prior is that a large
fraction of causal variants will have effect sizes close to zero. We would prefer to
count a variant as causal only if it has a sufficiently large effect size, using for
example a bi-modal prior distribution with probability mass separated from zero,
but for such prior, it was not feasible to accurately model the effects of the LD
structure.
In a joint analysis of two traits, we expect some variants to affect both traits;
some variants to affect one trait but not the other; and most variants to have no
effect on either trait. We assumed that for a given trait, all causal variants follow
the same distribution of effect sizes, regardless of what effect a variant has on the
other trait. Within the shared component, we model correlation of effect sizes, to
account for genetically correlated traits. Based on these assumptions, MiXeR
models additive genetic effects β1j, β2j of variant j on the two traits as a mixture
of four bivariate Gaussian components (Fig. 1):
β1j; β2j
 
 π0Nð0; 0Þ þ π1N 0;Σ1ð Þ þ π2N 0;Σ2ð Þ þ π12N 0;Σ12ð Þ; ð1Þ
Σ1 ¼
σ21 0
0 0
 
; Σ2 ¼
0 0
0 σ22
 
; Σ12 ¼
σ21 ρ12σ1σ2
ρ12σ1σ2 σ
2
2
 
ð2Þ
where π1 and π2 are weights of the unique components (variants with an effect
on the first trait only, and on the second trait only); π12 is a weighting of the
component affecting both traits; and π0 is a fraction of variants that are non-
causal for both traits, π0+ π1+ π2+ π12= 1; σ21 and σ
2
2 control expected
magnitudes of per-variant effect sizes; and ρ12 is the correlation coefficient of the
effect sizes in the shared component. All parameters are assumed to be the same
for all genetic variants.
The effects β^1j; β^2j
 
estimated by a GWAS, represent only proxies of the true
causal effects (β1j, β2j), which are distorted by limited sample size (poor statistical
power), cryptic relatedness within a GWAS sample, as well as LD between variants.
To disentangle these effects, we derive the likelihood term for observed GWAS
signed test statistics (z1j, z2j), incorporating effects of the LD structure (allelic
correlation rij between variants i and j); heterozygosity Hj= 2pj(1− pj), where pj is
the minor allele frequency of the j-th variant; the number of subjects genotyped per
variant (N1j and N2j); and variance distortion parameters σ201, σ
2
02, and ρ0.
Specifically (see Supplementary Note 1),
z1j; z2j
 
¼ δ1j; δ2j
 
þ N 0; 0ð Þ; σ
2
01 ρ0σ01σ02
ρ0σ01σ02 σ
2
02
" # !
; ð3Þ
δj ¼
ffiffiffiffiffiffi
Nj
q X
i
ffiffiffiffiffi
Hi
p
rijβj
The nine parameters of the model (π1; π2; π12; σ
2
1; σ
2
2; ρ12; σ
2
01; σ
2
02; ρ0) are fit by
direct optimization of the weighted log likelihood, with standard errors estimated
from the Observed Fisher’s Information matrix.
Forcing π12= 1 (so that π0= π1= π2= 0) reduces our model to an infinitesimal
assumption that underlies cross-trait LD score regression8. Under this constraint,
our model predicts that GWAS-signed test statistics follow a bivariate Gaussian
distribution with zero mean and variance–covariance matrix
Σj ¼ ‘j
N1jσ
2
1
ffiffiffiffiffiffiffiffiffiffiffiffiffi
N1jN2j
p
ρ12σ1σ2ffiffiffiffiffiffiffiffiffiffiffiffiffi
N1jN2j
p
ρ12σ1σ2 N2jσ
2
2
" #
þ σ
2
01 ρ0σ01σ02
ρ0σ01σ02 σ
2
02
" #
;
i.e., (z1j, z2j) ∼N(0, Σj), where ‘j ¼
P
i Hir
2
ij is the LD score (adjusted for
heterozygosity). This model is consistent with cross-trait LD score regression,
with expected chi-square statistics Eðz21jÞ, Eðz22jÞ, and cross-trait covariance E
(z1jz2j) being proportional to the LD score of j-th SNP, and parameters ρ0, σ01,
σ02 playing the role of LD score regression intercepts47. The only distinction
here is that we choose to model effect sizes that are independent of allele
frequency, leading to the incorporation of Hi into our model; this factor is
absent from the LD score regression model due to the assumption there of
effect sizes that are inversely proportional to Hi. Thus, MiXeR is a direct
extension of cross-trait LD score regression, which relaxes the infinitesimal
assumption.
Model for bivariate distribution of GWAS z-scores. We derive two models for
GWAS z-scores, which we call “fast model” and “full model”. The “fast model” is
quicker to run, and we use it to perform an initial search in the space of the model’s
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-10310-0 ARTICLE
NATURE COMMUNICATIONS |         (2019) 10:2417 | https://doi.org/10.1038/s41467-019-10310-0 | www.nature.com/naturecommunications 7
parameters. The “full model” is slower but more accurate, and we use it for a final
tuning of model estimates.
The “full model” for GWAS z-scores approximates (z1j, z2j) distribution of a
given GWAS SNP as a mixture of K= 20,000 bivariate normal distributions, all
having equal weight in the mixture. For each k= 1, …, K, we randomly draw the
location of causal variants (π1N causal variants specific to the first trait, π2N specific
to the second trait, and π12N shared causal variants, where N denotes the total
number of variants in the reference panel), and calculate the variance–covariance
matrix Σ′kj from equation (3), using estimated LD r
2 correlations between the
assumed causal variants and the GWAS SNP. Then
z1j; z2j
 
¼ δ1j; δ2j
 
þ N 0; 0ð Þ; σ
2
01 ρ0σ01σ02
ρ0σ01σ02 σ
2
02
" # !
; ð4Þ
δ1j=
ffiffiffiffiffiffi
N1j
q
; δ2j=
ffiffiffiffiffiffi
N2j
q 
 1
K
X
k¼1::K
N 0; 0ð Þ;Σ′kj
 
The “fast model” is derived from the method of moments (see Supplementary
Note 1):
δ1j=
ffiffiffiffiffiffi
N1j
p
; δ2j=
ffiffiffiffiffiffi
N2j
p   ð1 π′1jÞN 0; 0ð Þ þ π′1jN 0;Σ′1j h i
1 π′2j
 
N 0; 0ð Þ þ π′2jN 0;Σ′2j
 h i

1 π′12;j
 
N 0; 0ð Þ þ π′12;jN 0;Σ′12;j
 h i
;
ð5Þ
where ⊕ denotes convolution of probabilistic distribution functions (so that
right-hand side evaluates to a mixture of eight components), π′cj ¼ ‘jπc=ηj is
adjusted weight of mixture component (c∈ 1, 2, 12); Σ′cj ¼ ηjΣc is adjusted
variance–covariance matrix; ‘j ¼
P
i
Hir
2
ij is the LD score, adjusted for
heterozygosity48; and ηcj ¼ πc‘j þ 1 πcð Þ
P
i
H2i r
4
ijP
i
Hir
2
ij
	 

can be interpreted as shape
parameter that affects fourth and higher moments of the distribution. This model
explains second moments E Z21j
h i
, E [Z1jZ2j], E Z22j
h i
and fourth moments E Z41j
h i
,
E Z21jZ
2
2j
h i
, E Z42j
h i
of z-score distribution, and forms a theoretical basis for the
mixture model of sparse and ubiquitous effects49,50. Of interest is that the “fast
model” involves the forth power of allelic correlation r4ij, which is directly
proportional to kurtosis (measure of heavy tails) of z-score distribution.
LD structure estimation. To estimate the LD structure, we use 489 individuals
from the 1000 Genome project51 (phase 3 data), obtained from the LD score
regression website8,22,52. In total, 14 individuals were excluded due to related-
ness53. For simulations, LD scores were estimated from the actual genotypes that
we use to produce synthetic GWAS summary statistics. LD r2 coefficients were
calculated using PLINK54 with LD r2 cutoff of 0.05 and fixed window size of
50,000 SNPs, corresponding on average to a window of 16 centimorgans. We
deliberately chose a larger LD window compared with the LDSR-recommended
window of 1 centimorgan, because the later appears to truncate a noticeable part
of LD structure. At the same time, we did not observe an effect of using an
unbiased estimate55 of r2, thus fall back to the standard Pearson correlation
coefficient. We employ small integer compression56 for efficient storage of the
LD matrix.
Fit procedure. We fit the model by direct optimization of weighted log likelihood
F θð Þ ¼
X
j
wj log pdf ðzjjθÞ
 
; ð6Þ
where θ ¼ π1; π2; π12; σ21; σ22; ρ12; σ201; σ202; ρ0
 
is a vector of all parameters
being optimized, and weights wj chosen by random pruning (64 iterations at LD
r2 0.1). Optimization is done by the Nelder–Mead Simplex Method57 as
implemented in MATLAB’s fminsearch. First, we fit univariate parameters
separately for each trait, i.e., πu1 ; σ
2
1, σ
2
01 for the first trait, and similarly for the
second trait. Univariate fit employs a sequence of optimizations to ensure robust
convergence: first, we use the “fast model” under constraint πu1 ¼ 1 to find σ21;inf
and to initialize σ201; second, we use constraint π
u
1σ
2
1 ¼ σ21;inf to find initial values
of πu1 and σ
2
1, again with the “fast model”. Finally, we use the “full model” and
unconstrained optimization to jointly fit πu1 ; σ
2
1, σ
2
01 parameters. The same
procedure is repeated for the second trait, to find πu2 ; σ
2
2, σ
2
02. To improve
convergence, we parametrize univariate log-likelihood as a function of
log πu1σ
2
1
 
and log πu1=σ
2
1
 
, which represent almost independent dimensions of
the energy landscape. In bivariate optimization, we use the “fast model” and
constraint π12= 1 to estimate rg and ρ0. Then, we proceed with the “full model”
optimization of the parameters specific to the bivariate model (π12, ρ12),
constraining all other parameters to their univariate estimates, and also
constraining rg and ρ0 to the estimates from the infinitesimal model. The
additional analysis (Supplementary Tables 7, 9) uses right-censoring58 of z-
scores exceeding zt= 5.45, by using cumulative distribution function59 in the
log likelihood:
F θð Þ ¼
X
j:jzj jzt
wj log pdf ðzjjθÞ
 
þ
X
j:jzj j>zt
wj log cdf ðzmax jθÞð Þ ð7Þ
Standard error estimation. We estimate standard errors of all parameters
from the observed Fisher’s information, based on the “fast model”. It is
known from the likelihood optimization theory that the observed Fisher’s
information may not be suitable for a parameter near its boundary, which is
applicable to the mixture weights π1, π2, π12, and the correlation of effect sizes
ρ12. To mitigate this problem, we apply transformations— MATLAB’s logit
() for π1, π2, π12, exp() for σ21; σ
2
2; σ
2
01; σ
2
02, and erf() for ρ0, ρ12, and esti-
mated a variance–covariance matrix of errors in the transformed parameter
space. We validated that our estimates based on the observed Fisher’s infor-
mation are in good agreement with block jack-knife estimates. To estimate
standard errors for a function of the parameters, such as rg or h2, we incorporate
linear correlation among parameter errors in the transformed space. We sample
N= 1000 realizations of the parameter vector, calculating the function (e.g., rg
or h2) on each of them, and report the standard deviations. In cases when joint
hessian was not positive definite, we estimate marginal errors of fitted
parameters.
Akaike and Bayesian information criteria. We apply standard formulas and
estimate AIC= 2k− 2F and BIC ¼ k ln n 2F, where F is the log-likelihood from
Eqs. (6) or (7), k is the number of parameters (k= 2 for an infinitesimal model, and
k= 3 for causal mixture model), and n ¼Pj wj is the effective number of SNPs
(the sum of weights across all SNPs used to fit the model).
Large LD blocks. The log-likelihood cost function and the Q–Q plots apply a
weighting scheme to SNPs to 0avoid overcounting evidence from large LD blocks.
As an alternative to weighting by inverse LD score, we chose to infer the weights by
random pruning. This technique is a stochastic procedure which averages log-
likelihood function across repeatedly selected subsets of variants, such that for each
pair of variants i, j in a subset J the squared allelic correlation r2ij falls below a
certain threshold. Given T iterations of random pruning the log-likelihood function
can be calculated as follows:
F θð Þ ¼ 1
T
XT
t¼1
X
j2Jt
log pdf ðzjjθÞ
 
ð8Þ
which is equivalent to weighted log-likelihood F θð Þ ¼Pj wj log pdf zjjθ  
with weights wj= |{t:j∈ Jt}|/T, |S| denotes cardinality of set S. Random pruning
with stringent threshold r2= 0.1 justify independent modeling of the residuals in
Eq. (3) across SNPs, which otherwise would be correlated.
Heritability estimates. In an additive model, SNP heritability is defined as a sum
across all causal variants: σ2β
P
j:βj≠0
2pj 1 pj
 
, which we approximate from an
average heterozygosity of all variants in the reference: π1Htotalσ
2
β , where
Htotal ¼
P
j 2pj 1 pj
 
. To estimate the proportion of causal variants that explain
a certain fraction of heritability (Supplementary Fig. 11), we randomly sample N=
10,000 causal effects from the reference, draw their effects βj from normal dis-
tribution, sort according to β2j pj 1 pj
 
, and report the fraction of variants that
cumulatively account for 90% of heritability.
Genetic correlation. Parameter ρ12 in MiXeR defines the correlation of effect
sizes within the shared polygenic component. Genome-wide genetic correlation,
calculated across all SNPs, is related to ρ12 by the following formula that involves
polygenicity πu1 ¼ π1 þ π12 and πu2 ¼ π2 þ π12 of the traits, and polygenic over-
lap π12:
rg ¼ ρ12π12=
ffiffiffiffiffiffiffiffiffiffi
πu1π
u
2
p ð9Þ
For traits with K-fold difference in polygenicity (πu1 ¼ Kπu2 ), the formula
predicts an upper bound on genome-wide genetic correlation: rg  ρ12=
ffiffiffiffi
K
p
, where
equality holds if causal variants of the less polygenic trait form a subset of the
higher-polygenic trait.
Quantile–quantile plots. Univariate Q–Q plots and stratified Q–Q plots for the
model were constructed from pdfj(z) density as defined by Eq. (3), given fitted
parameters of the model and LD structure of j-th SNP, calculated across a fine grid
of z-scores ranging from 0 to 38 with 0.05 step. We average pdfj(z) across 1% of
randomly sampled SNPs, and numerically integrate the resulting probability
density function to convert it into a cumulated distribution function. Error bars on
data Q–Q plots represent the 95% binomial confidence interval
q ± 1:96
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
q 1 qð Þ=ntotal
p
, where q is the probability of observing a p-value as
extreme as, or more extreme then the chosen p-value, and ntotal is the effective
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number of SNPs after controlling for LD structure, which in our case was calcu-
lated as a sum of random pruning weights across all SNPs.
GWAS power curves. Causal mixture model can project the future of GWAS
discoveries, by estimating proportion S(N) of narrow-sense heritability captured by
genome-wide significant SNPs at a given sample size N. The S(N) is defined as
follows:
S Nð Þ ¼
P
j
R
z:jzjzt Cðz;N; jÞdzP
j
R
zC z;N; jð Þdz
; ð10Þ
where zt= 5.45 gives z-score corresponding to the standard genome-wide
significance threshold 5 ∙ 10−8, and C(z, N, j) ≡ P(z, N, j) ⋅ E(δ2|z, N, j) denotes a
posterior effect size E(δ2|z, N, j) of the non-centrality parameter δ2 for a GWAS
SNP j, given certain z-score, multiplied by a prior probability of observing that z-
score. Probability density function P(z, N, j) is given by Eq. (4), and E(δ2|z, N, j) can
be calculated from the Bayesian rule. Thus, C z;N; jð Þ ¼ R δ2P zjδð ÞP δ; jð Þdδ, where
zjδ  N δ; σ20
 
. Analytical expressions for C(z, N, j) and
R
z:jzjzt Cðz;N; jÞdz are
given in the Supplementary Note 1.
SNPs in the analysis. To enable a direct comparison of our model with LD score
regression, we use the same set of SNPs in our log-likelihood optimization, which
consists of approx. 1.1 million variants, subset of 1000 Genomes and HapMap360,
with MAF above 0.05, ambiguous SNPs excluded, imputation INFO above 0.9,
MHC and other long-range LD regions excluded. Calculation of the LD structure,
LD scores ‘j and shape parameter ηj are based on 9,997,231 SNPs from 1000
Genomes Phase 3 data, downloaded from LD score regression website. In simu-
lations we generate GWAS and estimate LD structure on a subset of 11,015,833
SNPs from 1000 Genomes Phase 3, with MAF above 0.002, call rate above 90%,
excluding duplicated RS numbers; the fit procedure was constrained to ~ 130 K
GWAS SNPs, keeping only HapMap3 SNPs, and pruning SNPs at LD r2 threshold
of 0.1.
LD score regression estimates. For dichotomous phenotypes, we used an
effective sample size of Neff= 4/(1/Ncase+ 1/Ncont) to account for imbalanced
numbers of cases and controls, both in MiXeR and in LD score regression. In
addition, we ran LDSR using MiXeR MAF model (using --per-allele flags in
LD score estimation), and show the results alongside with original LDSR estimates
(Supplementary Tables 7, 9). For case/control phenotypes heritability is reported
on the observed scale.
Simulations. In our simulations, we use a panel of N= 100,000 samples and
11,015,833 SNPs, generated by HapGen261 using 1000 Genomes51 data to
approximate the LD structure for European ancestry. To avoid relatedness across
individuals, we run HapGen2 for small disjoint chunks of about 2900 SNPs at a
time, 3920 chunks in total. The chunks were acting as additional recombination
hotspots, causing certain changes in the distribution of the LD scores (Supple-
mentary Fig. 20). However, the total amount of allelic correlation in the HapGen2
panel was still substantial, for example the median LD scores in the HapGen2 panel
was 66.4, versus 63.5 in the 1000 Genomes panel, which makes the HapGen2 panel
appropriate for our simulations.
We also validated that the HapGen2 panel shows no signatures of cryptic
relatedness and sample stratification. The “plink --pca” analysis of the
genotype matrix shows no signatures of sample stratification, as shown by the
scatter plot of the first and second principal components (Supplementary Fig. 20).
The “plink --genome” test found no related individuals (PI_HAT measure was
below 0.1 for all pairs of individuals). We use a subset of 115,267 SNPs in the
analysis, selected according to steps described in the PCA module of the Ricopili
GWAS pipeline.
For each simulation run, we use PLINK to obtain GWAS summary statistics,
including Wald’s test z-score and p-value, of two synthesized quantitative
phenotypes, with complete sample overlap between GWAS samples. Quantitative
phenotype yk of k-th sample is calculated via a simple additive genetic model,
yk ¼
P
j gkjβj þ ϵk , where gkj is the number of reference alleles for j-th SNP on k-th
sample, βj is causal effect size, and ϵ is the residual vector drawn from normal
distribution with zero mean and variance chosen in a way that sets heritability
h2= var(Gβ)/var(y) to a predefined level.
For the simulations shown in Fig. 2, we draw effect sizes (β1j, β2j) from the four-
component mixture model (Eq. (1)), varying polygenicity of each phenotype
(πu1 ¼ π1 þ π12 and πu2 ¼ π2 þ π12), and polygenic overlap (π12). We chose the
total polygenicity in both traits to be 3 × 10−3 or 3 × 10−4 and include an additional
scenario of uneven polygenicity (πu1 ¼3 × 10−3, πu2 ¼3 × 10−4). For each
combination πu1 ; π
u
2 and h2, we set polygenic overlap to be a fraction of total
polygenicity π12 ¼ f πu1 , choosing the fraction f from six equally spaced values (0.0
to 1.0 with a step of 0.2). Correlation of effect sizes ρ12 set to 0.0 or 0.5. Heritability
was set to 0.1, 0.4, or 0.7, which let us keep GWAS sample size constant (N=
100,000) because the distribution of GWAS z-scores depends on N and h2 only
through their product, h2 ×N (thus, simulations with N= 700,000 and h2= 0.1
would be equivalent to our scenario with N= 100,000 and h2= 0.7). Finally, for
each combination of heritability, polygenicity, polygenic overlap, and correlation of
effect sizes, we repeat simulations ten times.
For the simulations with differential enrichment, we simulate three levels of
polygenicity (3 K, 30 K, and 300 K causal variants), three levels of heritability (0.1,
0.4, and 0.7), and for each combination, generate 20 pairs of genetically
independent traits (except for having shared pattern of enrichment). To simulate
the enrichment, we keep a constant variance of effect sizes across all SNPs, but
modulate the probability of having causal variant proportionally to LDSR
regression coefficient. We use --per-allele flags in LD score estimation to run
simulations with the MiXeR MAF model.
For simulations with MAF-dependent architectures, we simulate effect sizes as
follows:
βj  πN 0;HSj σ2β
 
þ 1 πð ÞN 0; 0ð Þ ð11Þ
Parameter S= 0 corresponds to the MiXeR MAF model, S=−1 corresponds to
the LDSR MAF model. The same model is implemented in BayesS software19, thus
we choose parameter S from −0.25, −0.50, and −0.75, which corresponds to the
range of BayesS estimates observed on real GWAS data.
Data availability
The datasets analyzed during the current study are freely available for download from the
following URLs: LD scores and reference panel derived from 1000 Genomes phase 3,
https://data.broadinstitute.org/alkesgroup/LDSCORE/; Psychiatric Genomics
Consortium (psychiatric disease), https://www.med.unc.edu/pgc/results-and-downloads/
downloads; SSGAC (educational attainment), https://www.thessgac.org/data; GIANT
Consortium, https://portals.broadinstitute.org/collaboration/giant; Early Growth
Genetics Consortium, http://egg-consortium.org/birth-weight-2016.html; Rheumatoid
arthritis, http://plaza.umin.ac.jp/~yokada/datasource/software.htm; International
Inflammatory Bowel Disease Genetics Consortium, https://www.ibdgenetics.org/.
Code availability
MiXeR software and a tutorial example on how to use it are available online (https://
github.com/precimed/mixer, v0.9.1); PLINK software (v1.90b5.2, 64-bit, 9 Jan 2018),
https://www.cog-genomics.org/plink2; LD score regression software, v1.0.0, https://
github.com/bulik/ldsc; HapGen2 software, v2.2.0, http://mathgen.stats.ox.ac.uk/
genetics_software; pipeline to harmonize GWAS summary statistics: https://github.com/
precimed/python_convert (v0.9.1); pipeline to simulate synthetic GWAS data from
genotypes: https://github.com/precimed/simu (v0.9.3).
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